A high-ranking Viatris government was charged with insider buying and selling for tipping a good friend and former colleague about earnings, drug approvals, and a pending merger with a Pfizer division.
In courtroom paperwork, federal authorities alleged that Ramkumar Rayapureddy, the chief data officer on the drug firm, which was beforehand generally known as Mylan, supplied “materials” data to Dayakar Mallu, who additionally labored within the IT division. In change, Mallu shared a portion of his illicit buying and selling income with Rayapureddy by money funds made in India.
